VP2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Valeo Pharma Inc

Watchlist Manager

Watchlist

Price: 0.005 EUR

Market Cap: €832.5k

	Valeo Pharma Inc F:VP2	CA
O	OC Oerlikon Corporation AG Pfaeffikon XMUN:OBH	CH
A	Alpha Pro Tech Ltd AMEX:APT	CA
	Straumann Holding AG F:QS5	CH

Profitability Summary

Valeo Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

22%

Declining Gross Margin

25% > 17%

Negative Operating Margin

-36%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-38% > -36%

Negative Net Margin

-60%

Negative 3Y Average Net Margin

-55%

Net Margin is Increasing

-61% > -60%

Negative Free Cash Flow Margin

-17%

Negative 3Y Average Free Cash Flow Margin

-33%

Free Cash Flow Margin is Increasing

-70% > -17%

Exceptional ROE

65%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-94%

Declining ROIC

-88% > -137%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.